Care for patients with Duchenne muscular dystrophy (DMD) is poorly standardised. There are many interventions in different systems which are known to improve outcomes in DMD but these are not uniformly applied. This leads to inequality in access to treatment, as well as problems for planning controlled trials of future therapeutics. A worldwide effort is underway to generate care guidelines for DMD, which involves the Centre for Disease Control in the USA and the TREATNMD network of excellence for neuromuscular diseases in Europe. In advance of the full consensus document, TREAT-NMD has worked on the generation of brief standards of care for DMD, which are presented here and are available via the TREAT-NMD website (www.treat-nmd.eu). Guidelines are presented for diagnostics, neurological follow up, gastrointestinal and nutritional issues, respiratory and cardiac care as well as orthopaedics, rehabilitation, psychosocial interventions and oral care. © Springer Science+Business Media B.V. 2009.
CITATION STYLE
Sejerson, T., Bushby, K., & On Behalf of the TREAT-NMD EU Network of Excellence. (2009). Standards of care for duchenne muscular dystrophy: Brief treat-NMD recommendations. In Advances in Experimental Medicine and Biology (Vol. 652, pp. 13–21). Springer New York LLC. https://doi.org/10.1007/978-90-481-2813-6_2
Mendeley helps you to discover research relevant for your work.